Pathogen-specific Therapy

Pathogen-Specific Therapy is a targeted antimicrobial strategy that belongs to the class of precision infectious disease interventions and is distinguished by its reliance on definitive microbiological identification and antimicrobial susceptibility testing to guide the selection of a narrow-spectrum agent directed exclusively against the confirmed causative pathogen.

36

Publications

2.1K

Citations

277

Authors

123

Institutions

Publications per year

2017–2026

17

Authors

277

  1. YT
    Yi‐Wei Tang

    Memorial Sloan Kettering Cancer Center, United States

    2 publications · 43 citations

    2

    h-index

  2. JJ
    Jamese J. Hilliard

    Johnson & Johnson (United States), United States

    2 publications · 62 citations

    2

    h-index

  3. CK
    C. Ken Stover

    AstraZeneca (United States), United States

    2 publications · 62 citations

    2

    h-index

  4. JK
    Jay K. Varma

    Centers for Disease Control and Prevention, United States

    1 publications · 12 citations

    1

    h-index

  5. RD
    Ruihua Dong

    Southern University of Science and Technology, China

    1 publications · 122 citations

    1

    h-index

1–5 of 277

Venues

  1. Antimicrobial Agents and Chemotherapy

    AAC · 3 publications · 99 citations

    3

    h-index

  2. ACS Nano

    2 publications · 239 citations

    2

    h-index

  3. PubMed

    Repository · 2 publications · 56 citations

    2

    h-index

  4. Annals of Internal Medicine

    2 publications · 54 citations

    2

    h-index

  5. The Pediatric Infectious Disease Journal

    PIDJ · 1 publications · 44 citations

    1

    h-index

1–5